AcouSort AB (publ) (FRA:4SA)

Market Cap	7.59M +44.7%
Revenue (ttm)	963.95K +4.0%
Net Income	-1.12M
EPS	-0.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.2940
Previous Close	0.2270
Day's Range	0.2940 - 0.2940
52-Week Range	0.1240 - 0.3170
Beta	n/a
RSI	57.38
Earnings Date	May 22, 2026

About AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrumen...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2010
• Employees: 16
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4SA

Financial Performance

In 2025, AcouSort AB's revenue was 10.43 million, an increase of 4.01% compared to the previous year's 10.03 million. Losses were -12.15 million, -19.40% less than in 2024.

Financial numbers in SEK